AYR Wellness Earnings + Call Notes
Leveraged to states transitioning to adult-use.
$114.8M Revs; est. $114.5M
$29.8M AEBITDA: est. $28.1M
$49.4M GP; est. $50.2M
$(9.5M) OI; est. ($2M)
46.3% GM; est. 43.8%
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.